Equities

Lineage Cell Therapeutics Inc

Lineage Cell Therapeutics Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (ILa)344.90
  • Today's Change14.20 / 4.29%
  • Shares traded59.85k
  • 1 Year change-18.85%
  • Beta--
Data delayed at least 20 minutes, as of Nov 07 2024 15:24 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Historical Prices

DateOpenHighLowCloseVolume
Thursday, November 07, 2024Thu, Nov 07, 2024327.00344.90327.00344.9059,85259.85k
Wednesday, November 06, 2024Wed, Nov 06, 2024323.50330.70318.00330.7044,36544.37k
Tuesday, November 05, 2024Tue, Nov 05, 2024311.00326.90311.00326.902,6022.60k
Monday, November 04, 2024Mon, Nov 04, 2024323.20323.20306.50308.2027,71227.71k
Sunday, November 03, 2024Sun, Nov 03, 2024317.50324.30312.70313.506,0576.06k
Thursday, October 31, 2024Thu, Oct 31, 2024328.20333.70316.40318.9034,46734.47k
Wednesday, October 30, 2024Wed, Oct 30, 2024329.40335.30323.00325.2020,38520.39k
Tuesday, October 29, 2024Tue, Oct 29, 2024322.00345.60320.30331.5023,61223.61k
Monday, October 28, 2024Mon, Oct 28, 2024328.00328.00319.10322.9018,17418.17k
Sunday, October 27, 2024Sun, Oct 27, 2024324.60337.00324.60335.108,9028.90k
Tuesday, October 22, 2024Tue, Oct 22, 2024323.80326.90321.60325.8014,91214.91k
Monday, October 21, 2024Mon, Oct 21, 2024327.50329.60319.40327.8021,49421.49k
Sunday, October 20, 2024Sun, Oct 20, 2024330.00330.00324.00327.507,6827.68k
Tuesday, October 15, 2024Tue, Oct 15, 2024323.30326.80317.90317.9013,91913.92k
Monday, October 14, 2024Mon, Oct 14, 2024321.00326.90321.00326.408,1238.12k
Sunday, October 13, 2024Sun, Oct 13, 2024327.30339.90317.10317.108,0298.03k
Thursday, October 10, 2024Thu, Oct 10, 2024321.10330.40321.10328.1012,37212.37k
There are no Historical Prices for the selected date range, please select a different date.
Data delayed at least 20 minutes, as of Nov 07 2024 17:24 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.